Invention of 3Mint for feature grouping and scoring in multi-omics

dc.contributor.author Yazici, Miray Unlu
dc.contributor.author Marron, J. S.
dc.contributor.author Bakir-Gungor, Burcu
dc.contributor.author Zou, Fei
dc.contributor.author Yousef, Malik
dc.contributor.authorID 0000-0002-2272-6270 en_US
dc.contributor.department AGÜ, Mühendislik Fakültesi, Bilgisayar Mühendisliği Bölümü en_US
dc.contributor.institutionauthor Bakir-Gungor, Burcu
dc.date.accessioned 2023-07-18T09:44:22Z
dc.date.available 2023-07-18T09:44:22Z
dc.date.issued 2023 en_US
dc.description.abstract Advanced genomic and molecular profiling technologies accelerated the enlightenment of the regulatory mechanisms behind cancer development and progression, and the targeted therapies in patients. Along this line, intense studies with immense amounts of biological information have boosted the discovery of molecular biomarkers. Cancer is one of the leading causes of death around the world in recent years. Elucidation of genomic and epigenetic factors in Breast Cancer (BRCA) can provide a roadmap to uncover the disease mechanisms. Accordingly, unraveling the possible systematic connections between-omics data types and their contribution to BRCA tumor progression is crucial. In this study, we have developed a novel machine learning (ML) based integrative approach for multi-omics data analysis. This integrative approach combines information from gene expression (mRNA), microRNA (miRNA) and methylation data. Due to the complexity of cancer, this integrated data is expected to improve the prediction, diagnosis and treatment of disease through patterns only available from the 3-way interactions between these 3-omics datasets. In addition, the proposed method bridges the interpretation gap between the disease mechanisms that drive onset and progression. Our fundamental contribution is the 3 Multi-omics integrative tool (3Mint). This tool aims to perform grouping and scoring of groups using biological knowledge. Another major goal is improved gene selection via detection of novel groups of cross-omics biomarkers. Performance of 3Mint is assessed using different metrics. Our computational performance evaluations showed that the 3Mint classifies the BRCA molecular subtypes with lower number of genes when compared to the miRcorrNet tool which uses miRNA and mRNA gene expression profiles in terms of similar performance metrics (95% Accuracy). The incorporation of methylation data in 3Mint yields a much more focused analysis. The 3Mint tool and all other supplementary files are available at . en_US
dc.description.sponsorship efat Academic College National Science Foundation (NSF) DMS-2113404 Abdullah Gul University en_US
dc.identifier.endpage 17 en_US
dc.identifier.issn 1664-8021
dc.identifier.other WOS:000960452700001
dc.identifier.startpage 1 en_US
dc.identifier.uri https://doi.org/10.3389/fgene.2023.1093326
dc.identifier.uri https://hdl.handle.net/20.500.12573/1639
dc.identifier.volume 14 en_US
dc.language.iso eng en_US
dc.publisher FRONTIERS MEDIA SA en_US
dc.relation.isversionof 10.3389/fgene.2023.1093326 en_US
dc.relation.journal FRONTIERS IN GENETICS en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject multi-omics en_US
dc.subject machine learning en_US
dc.subject breast cancer, en_US
dc.subject integrative analysis en_US
dc.subject miRNA en_US
dc.title Invention of 3Mint for feature grouping and scoring in multi-omics en_US
dc.type article en_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
fgene-14-1093326.pdf
Size:
3.39 MB
Format:
Adobe Portable Document Format
Description:
Makale Dosyası

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.44 KB
Format:
Item-specific license agreed upon to submission
Description: